| Aug 16 |
How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?
|
| Aug 16 |
FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer
|
| Aug 16 |
AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting
|
| Aug 16 |
Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal
|
| Aug 16 |
FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer
|
| Aug 16 |
AstraZeneca Imfinzi label expanded in U.S. for lung cancer
|
| Aug 16 |
IMFINZI® (durvalumab) approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery
|
| Aug 16 |
AstraZeneca’s sBLA for LS-SCLC treatment gains FDA priority review
|
| Aug 15 |
These 10 drugs will be cheaper after Medicare negotiations
|
| Aug 15 |
Medicare negotiates lower prices for 10 high-cost drugs
|
